Eradication of Polio in the World; Iran is at Risk for Reemerging of Polio: A Review of the Literature

被引:3
作者
Razavi, Seyed Mansour [1 ]
Mardani, Masoud [2 ]
Salamati, Payman [3 ]
机构
[1] Univ Tehran Med Sci, Dept Community Med, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Infect Dis & Trop Med Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran
来源
ARCHIVES OF CLINICAL INFECTIOUS DISEASES | 2016年 / 11卷 / 04期
关键词
Poliomyelitis; Communicable Disease Control; Iran;
D O I
10.5812/archcid.36867
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Context: The wild polio virus is disrupted in all countries in the world, except Afghanistan and Pakistan, the two neighboring countries of Iran. Because of illegal migrations and some geographical, socioeconomic and managerial problems, Iran is exposed to reemerging of the disease. The current study aimed to assess the condition of the disease in Iran and propose preventive measures. Evidence Acquisition: Authors extracted and evaluated 33 relevant articles among 189 polio related abstracts. The key words were: polio, poliomyelitis, polio eradication, oral polio vaccine (OPV), inactivated polio vaccine (IPV), acute flaccid paralysis (AFP), vaccination derived paralysis (VDP) and Iran. PubMed was used as an international site and IranMedex as a national motor search to assess the subject. Results: Since 2001, Iran is recognized as a polio free country by world health organization (WHO). Afghanistan and Pakistan, the two neighboring countries of Iran, are still infected with wild poliovirus. About 2.5 million Afghan refugees live in Iran and they communicate with their compatriots. Iran and its neighbors are different regarding vaccination coverage rates, rate of access to safe drinking water, political, security and cultural issues, health system and managerial indicators. Conclusions: Health managers in Iran should continuously monitor the coverage of vaccination with at least three doses of OPV in the level of over 95%, monitor the health of the Helmand River water which comes from Afghanistan to Iran, vaccinate the immigrants and replace bivalent vaccine (bOPV) with trivalent (tOPV) vaccine.
引用
收藏
页数:7
相关论文
共 38 条
[21]  
Moussavi T, 2012, ARCH IRAN MED, V15, P107, DOI 012152/AIM.0013
[22]  
Naeini Alireza Emami, 2015, Adv Biomed Res, V4, P99, DOI 10.4103/2277-9175.156670
[23]   Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency [J].
Parvaneh, Nima ;
Shahmahmoudi, Shohreh ;
Tabatabai, Hamideh ;
Zahraei, Mohsen ;
Mousavi, Taha ;
Esteghamati, Abdol-Reza ;
Gooya, Mohammad M. ;
Mamishi, Setareh ;
Nategh, Rakhshandeh ;
Kew, Olen M. .
JOURNAL OF CLINICAL VIROLOGY, 2007, 39 (02) :145-148
[24]   Polio endgame: the global introduction of inactivated polio vaccine [J].
Patel, Manish ;
Zipursky, Simona ;
Orenstein, Walt ;
Garon, Julie ;
Zaffran, Michel .
EXPERT REVIEW OF VACCINES, 2015, 14 (05) :749-762
[25]   Role of genetic factors in polio eradication: New challenge for policy makers [J].
Paul, Yash .
VACCINE, 2007, 25 (50) :8365-8371
[26]   Evaluation of Acute Flaccid Paralysis in Hamadan, Iran from 2002 to 2009 [J].
Poorolajal, Jalal ;
Ghasemi, Shadi ;
Farahani, Leila Nezamabadi ;
Hosseini, Atefeh Sadat ;
Bathaei, Seyyed Jalal ;
Zahiri, Ali .
EPIDEMIOLOGY AND HEALTH, 2011, 33
[27]   Characterization of mutations in the VP1 region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran [J].
Rahimi, Pooneh ;
Tabatabaie, H. ;
Gouya, Mohammad M. ;
Zahraie, Mohsen ;
Mahmudi, M. ;
Ziaie, A. ;
Rad, K. Samimi ;
Shahmahmudi, Sh. ;
Musavi, T. ;
Azad, T. Mokhtari ;
Nategh, R. .
JOURNAL OF CLINICAL VIROLOGY, 2007, 39 (04) :304-307
[28]  
Salehiomran MR, 2012, CASP J INTERN MED, V3, P425
[29]   Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature [J].
Shaghaghi, Mohammadreza ;
Parvaneh, Nima ;
Ostad-Rahimi, Pouya ;
Fathi, Seyed Mohammad ;
Shahmahmoodi, Shohreh ;
Abolhassani, Hassan ;
Aghamohammadi, Asghar .
IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (03) :292-298
[30]   Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia [J].
Shahmahmoodi, Shohreh ;
Parvaneh, Nima ;
Burns, Cara ;
Asghar, Humayun ;
Mamishi, Setareh ;
Tabatabaie, Hamideh ;
Chen, Qi ;
Teimourian, Shahram ;
Gooya, Mohammad Mehdi ;
Esteghamati, Abdol-Reza ;
Mousavi, Taha ;
Yousefi, Maryam ;
Farrokhi, Kobra ;
Mashlool, Maryam ;
Kew, Olen ;
Nategh, Rakhshandeh .
VIRUS RESEARCH, 2008, 137 (01) :168-172